期刊文献+

HPLC测定彝肤软膏中重楼皂苷Ⅰ,Ⅱ的含量 被引量:4

Studies on quality standard of Yifu ointment
下载PDF
导出
摘要 目的:建立同时测定彝肤软膏中重楼皂苷Ⅰ、重楼皂苷Ⅱ高效液相色谱分析方法。方法:采用高效液相色谱法对彝肤软膏中重楼皂苷Ⅰ、重楼皂苷Ⅱ同时进行含量测定:Hypersil ODS2(4.6mm×150mm,5μm);预柱:IBBM-612111,C-18柱芯;乙腈-0.02%磷酸(43:57)为流动相,流速1mL·min^-1,检测波长203nm,柱温40℃。结果:重楼皂苷Ⅰ在0.1024~3.2μg线形关系良好,r=0.9998,平均回收率97.4%,RSD1.8%(n=6);重楼皂苷Ⅱ在0.064—2.0μg线形关系良好,r=0.9999,平均回收率101.4%,RSD1.0%(n=6)。结论:本方法准确可靠、重复性好,能有效控制该制剂的质量。 Objective: To develop a method for the determination of Chonglou saponin Iand Chonglou saponin II in Yifu ointment. Method: The chromatographic separation was performed on Hypersil ODS2 C18 column (4. 6 mm × 150 mm, 5 μm) and IBBM-612111 ODS C18 guard column. Acetonitrile-0. 02% phosphoric (43: 57) as mobile phase. The flow rate was 1 mL · min^-1 and column temperature was set at 40 ℃. The UV detection wavelength was set 203 nm. Result: Chonglou saponinIshowed a good linear relationship at a range of 0. 102 4-3. 2 μg, r =0. 999 8, the average recovery was 97. 4%, and RSD was 1.8% ( n = 6) ; Chonglou saponin Ⅱ showed a good linear relationship at a range of 0. 064-2. 0 μg, r =0. 999 9, the average recovery was 101.4%, and RSD was 1.0% (n =6). Conclusion: The method is accurate with the good reproducibility and can be used for the quality control of Yifu Ointment.
出处 《中国中药杂志》 CAS CSCD 北大核心 2007年第22期2368-2370,共3页 China Journal of Chinese Materia Medica
基金 四川省中医药管理局民族药重点项目(2004A09)
关键词 彝肤软膏 重楼皂苷Ⅰ重楼皂苷Ⅱ 含量测定 Yifu ointment chonglou saponin Ⅰ chonglou saponin Ⅱ quantitative detemination
  • 相关文献

参考文献3

二级参考文献15

  • 1裴盛基.传统医药现代化与民族医药的传承[J].中国民族民间医药杂志,2000,(42):1-3. 被引量:12
  • 2Balick M.J,Cox P.A..Plants,People and Culture:The Science of Ethnobotany. Scientific American Library, New York :996,8. 被引量:1
  • 3Heinrich M., Anita A., Frei B.,et al. Medicinal Plants in Mexico: Healers' Consensus and Cultural Importance. Social Science and Medicine, 1998 ;47: 859~871. 被引量:1
  • 4Fabricant D.S.,Farnsworth N.R..The Value of Plants Used in Traditional Medicine for Drug Discovery. Environmental Health Perspectives, 2001; 109(suppl 1): 69~75. 被引量:1
  • 5Mans D.R.A.,Rocha A.B.D.,Schwartsmann G..Anti-cancer drug discovery and development in Brazil:Targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. The Oncologist. ,2000;5:185~198. 被引量:1
  • 6Cox P.A.,Balick M.J..The ethnobotanical approach to drug discov-ery.Scientific American, 1994,6: 60~65. 被引量:1
  • 7张艺 钟国跃.羌族医药[M].北京:中国文史出版社,2005.320. 被引量:3
  • 8Slish D.F.,Ueda h.,Arvigo R.,et al. Ethnobotany in the search for vasoactive herbal medicines.Journal of Ethnopharmacology, 1999;66:159~165. 被引量:1
  • 9Khafagi I.K.,Dewedar A..The efficiency of random versus ethnodirected research in the evaluation of Sinai medicinal plants for bioac-tive compounds Journal of Ethnopharmacology,2000;71 (3):365~376. 被引量:1
  • 10S.Rubinand.C.Fish, Biodiversity prospecting: using innovative contractual provisions to foster ethnobotanical knowledge, technology and conservation, Colorado Journal of International Law and Policy 5, 23 ~58. 被引量:1

共引文献224

同被引文献59

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部